Skip to content

13F-HR filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-12, with 41 holding rows worth $210,939,687.

Accession
0001420506-23-001021
Filed
2023-05-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 41 entries on the cover page, a total value of $210,939,687 stated on the cover page (in dollars after the unit check, H1), rows summing to $210,939,687 with VALUE read as dollars as filed, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PROTHENA CORP PLC SHSG72800108Stock447,092$21,670,549dollars as filed
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR375,500$14,509,320dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM567,826$13,639,181dollars as filed
HUMANA INC COM444859102Stock24,000$11,651,040dollars as filed
CENTENE CORP DEL COM15135B101Stock161,404$10,202,347dollars as filed
KEZAR LIFE SCIENCES INC49372L100COM3,200,000$10,016,000dollars as filed
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock1,074,593$8,962,105dollars as filed
ALKERMES PLCG01767105SHS316,165$8,912,691dollars as filed
HORIZON THERAPEUTICS PLCG46188101SHS81,035$8,844,160dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM1,545,000$8,806,500dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM80,000$8,097,600dollars as filed
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK1,488,917$7,697,701dollars as filed
ADC THERAPEUTICS SAH0036K147COMMON STOCK3,257,360$6,351,852dollars as filed
ARCTURUS THERAPEUTICS HLDGS03969T109COM255,000$6,112,350dollars as filed
SHATTUCK LABS INC82024L103COMMON STOCK2,021,668$5,943,704dollars as filed
ABCELLERA BIOLOGICS INC COM00288U106Stock753,528$5,681,601dollars as filed
UnitedHealth Group Inc91324P102COM10,935$5,167,772dollars as filed
OPTION CARE HEALTH INC COM NEW68404L201Stock154,900$4,921,173dollars as filed
QUIDELORTHO CORP COM219798105Stock48,355$4,307,947dollars as filed
CUE BIOPHARMA INC22978P106COM1,151,855$4,112,122dollars as filed
Johnson & Johnson478160104COM25,210$3,907,550dollars as filed
INARI MED INC45332Y109COM62,081$3,832,881dollars as filed
ALDEYRA THERAPEUTICS INC01438T106COM383,447$3,807,629dollars as filed
PACIRA BIOSCIENCES INC COM695127100Stock91,123$3,718,730dollars as filed
LONGBOARD PHARMACEUTICALS IN54300N103COM900,600$3,611,406dollars as filed
ERASCA INC COM29479A108Stock1,179,090$3,549,061dollars as filed
COMPASS THERAPEUTICS INC20454B104COM678,300$2,218,041dollars as filed
GRAPHITE BIO INC38870X104COM876,666$2,147,832dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM240,000$1,886,400dollars as filed
GALAPAGOS NV36315X901SPON ADR40,000$1,545,600dollars as filedcall
ModivCare Inc60783X104Common Stock15,452$1,299,204dollars as filed
TELADOC HEALTH INC87918A105COM45,900$1,188,810dollars as filed
KEZAR LIFE SCIENCES INC49372L900CALL200,000$626,000dollars as filedcall
INSMED INC COM PAR $.01457669307Stock26,359$449,421dollars as filed
2SEVENTY BIO INC COMMON STOCK901384107Stock42,537$433,877dollars as filed
MORPHIC HLDG INC61775R105COM8,464$318,585dollars as filed
ELUTIA INC05479K106CL A COM196,443$296,629dollars as filed
BRIDGEBIO PHARMA INC10806X102COM13,000$215,540dollars as filed
STARLING ONCOLOGY INC68236X100COMMON STOCK281,902$191,101dollars as filed
LIFESTANCE HEALTH GROUP INC53228F101COM9,000$66,870dollars as filed
SPDR SER TR78464A870S&P BIOTECH273$20,805dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-23-001021this filing2023-05-12acceptance time not in the bulk data set